ÂÜÀòÂÒÂ×

Mark Mitchell is an experienced finance professional in the biotechnology and pharmaceutical sectors, currently serving as Senior Director of R&D Finance at Alexion Pharmaceuticals, Inc. since May 2024. Previous roles include Vice President of Financial Planning & Analysis at Scholar Rock and positions at Genentech, where Mark held various director and managerial roles in finance. Additional experience includes working as an Angel Investor at Life Science Angels and holding analyst positions at Roche and Canaccord Genuity. Mark holds a Bachelor of Science with Honours in Biology from Queen's University, a Master of Science in Molecular Virology from McMaster University, and an MBA in Finance and Marketing from Wilfrid Laurier University.